BEDSIDE ACTION BOX — Baby of a Mother with Preeclampsia
- Two big drivers of neonatal risk: prematurity from indicated delivery and placental insufficiency (growth restriction, perinatal hypoxia).
- If the mother received magnesium sulfate, anticipate a floppy, apneic, or poorly feeding baby — have resuscitation ready and monitor tone/respiration.
- At birth expect the growth-restricted infant: watch for hypothermia, hypoglycemia, and polycythemia.
- Check a CBC — neutropenia and thrombocytopenia are common in infants of preeclamptic mothers, especially with growth restriction or HELLP.
- Provide warmth, early feeding, and glucose monitoring; escalate for respiratory distress or perinatal depression.
1. Overview & Definition
Definition
Preeclampsia is a pregnancy-specific disorder of placental origin: abnormal placentation leads to maternal endothelial dysfunction, new-onset hypertension, and end-organ involvement after 20 weeks. For the neonatal team, preeclampsia matters as a leading cause of medically indicated preterm birth and fetal growth restriction, with several predictable effects on the newborn.
Why This Topic Matters
The baby's problems flow from three sources: the prematurity of an early indicated delivery, chronic placental insufficiency in utero, and the transplacental effects of maternal treatment (particularly magnesium). Recognizing this trio lets you anticipate rather than react.
2. Who This Guideline Applies To
Scope
- Infants born to mothers with gestational hypertension, preeclampsia/eclampsia, or HELLP syndrome.
- Growth-restricted infants delivered for maternal or fetal indications related to hypertensive disease.
- Cross-references: fetal growth restriction (13.4); antenatal steroids & magnesium (13.3); hypoglycemia (4.x); polycythemia (10.x); thrombocytopenia (10.x).
3. Pathophysiology — Why the Baby Is Affected
Preeclampsia begins with defective remodeling of the spiral arteries, so the placenta is chronically underperfused. The ischemic placenta releases anti-angiogenic factors that injure the maternal endothelium (hypertension, proteinuria) and, on the fetal side, limit oxygen and nutrient delivery.
| Source of neonatal risk | Clinical consequence |
|---|
| Placental insufficiency | Fetal growth restriction, oligohydramnios, abnormal umbilical artery Dopplers, perinatal hypoxia, stillbirth risk |
| Indicated preterm delivery | All the morbidities of prematurity (RDS, IVH, feeding immaturity, temperature instability) |
| Chronic intrauterine hypoxia | Increased erythropoietin → polycythemia; low glycogen/fat stores → hypoglycemia, hypothermia |
| Placental/marrow effects | Neutropenia and thrombocytopenia (more common with FGR and HELLP) |
| Maternal magnesium sulfate | Transplacental hypermagnesemia → neonatal hypotonia, respiratory depression, feeding difficulty |
4. Markers of a More Affected Infant
Higher-Risk Situations
- Early-onset, severe preeclampsia requiring very preterm delivery.
- HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) — signals severe disease and often urgent delivery.
- Significant fetal growth restriction with abnormal Doppler studies (absent/reversed end-diastolic flow).
- Prolonged or high-dose maternal magnesium therapy near delivery.
5. Clinical Presentation
What You See at the Bedside
- Growth-restricted, often preterm infant — thin, with reduced subcutaneous fat.
- Magnesium effect: hypotonia, lethargy, poor respiratory effort or apnea, weak suck in the first hours.
- Metabolic: hypoglycemia and hypothermia from low reserves; plethora if polycythemic.
- Hematologic: may be discovered on CBC — neutropenia, thrombocytopenia.
- Respiratory: distress from prematurity/RDS or perinatal depression.
6. Recommended Workup
What to Check
- Glucose: screen for hypoglycemia per the at-risk protocol (growth restriction is a risk factor).
- Temperature: active thermoregulation from birth.
- CBC with differential and platelets: look for neutropenia and thrombocytopenia; hematocrit for polycythemia.
- Respiratory assessment: for RDS/TTN in the preterm or depressed infant.
- Magnesium level: if the infant is significantly hypotonic or apneic after heavy maternal magnesium exposure.
7. Delivery-Room & First-Hours Plan
1
Anticipate
Know the gestation, growth status, Doppler findings, and magnesium exposure before delivery; prepare for prematurity and possible perinatal depression.
2
Resuscitate and warm
Standard NRP; expect the magnesium-exposed infant to need respiratory support; aggressive thermoregulation for the small infant.
3
Stabilize metabolically
Early feeding or IV dextrose; monitor glucose closely; check hematocrit if plethoric.
4
Screen hematology
CBC for neutropenia/thrombocytopenia; repeat as indicated — counts may fall over the first days.
5
Monitor and support
Watch respiration and tone until the magnesium effect resolves; support feeding and growth.
8. Management of the Associated Problems
| Problem | Approach |
|---|
| Prematurity | Standard preterm care (respiratory support, thermoregulation, nutrition, screening). |
| Growth restriction | Thermoregulation, early feeding, glucose monitoring; watch for polycythemia and feeding intolerance. |
| Magnesium effect | Supportive — respiratory support and gavage feeds until it clears; usually self-limited over 24–72 hours. |
| Neutropenia | Usually transient; monitor and consider sepsis evaluation if clinically unwell. |
| Thrombocytopenia | Monitor; transfuse only per threshold with bleeding or very low counts. |
| Polycythemia | Hydration; partial exchange only for symptomatic, very high hematocrit. |
9. Monitoring
What to Track
- Glucose and temperature until stable on feeds.
- Serial CBC/platelets while counts are low or falling.
- Respiratory status and tone until the magnesium effect resolves.
- Growth and feeding tolerance.
10. Contraindications & Precautions
Safety Cautions
- Do not attribute early apnea/hypotonia solely to magnesium without excluding sepsis, hypoglycemia, and hypoxic injury.
- Do not miss falling platelet or neutrophil counts — recheck over the first days rather than a single CBC.
- Do not under-treat hypothermia and hypoglycemia in the small, growth-restricted infant.
- Do not overlook that severe preeclampsia/HELLP can coexist with perinatal hypoxia.
11. Escalation & Follow-Up
Escalate When…
- Persistent apnea/respiratory depression beyond the expected magnesium window.
- Severe or bleeding-associated thrombocytopenia, or profound neutropenia with clinical instability.
- Signs of perinatal hypoxic-ischemic injury or refractory hypoglycemia.
Discharge & Follow-Up
- Stable glucose and temperature on feeds; counts recovering; feeding established.
- Growth-restricted and preterm infants enter the appropriate neurodevelopmental and growth follow-up pathways.
- Counsel on the mother's increased long-term cardiovascular risk and recurrence in future pregnancies.
Parent Counselling Points
- "Your blood-pressure condition meant the safest plan was to deliver early, so some of what we watch for is simply about prematurity."
- "The placenta was working harder than usual, so your baby may be small and needs help staying warm and keeping sugars up at first."
- "The magnesium you received can make babies sleepy and floppy for a day or two — it wears off, and we support breathing and feeding until it does."
12. Key Pearls
High-Value Clinical Pearls
- Think in three streams: prematurity, placental insufficiency, and maternal magnesium — they explain almost every finding.
- Neutropenia and thrombocytopenia are classic in infants of preeclamptic mothers, especially with FGR/HELLP.
- The growth-restricted infant is prone to hypothermia, hypoglycemia, and polycythemia at birth.
- Magnesium-related hypotonia and apnea are transient — support, don't over-investigate, once sepsis and hypoglycemia are excluded.
- Preeclampsia is a placental disease; the definitive maternal cure is delivery, which is why prematurity is so common.
13. Common Mistakes to Avoid
Pitfalls & Better Practice
The recurring errors when caring for the infant of a preeclamptic mother.
| Mistake | Why it harms | Better practice |
|---|
| Blaming all apnea on magnesium. | Misses sepsis, hypoglycemia, or hypoxic injury. | Exclude other causes, then attribute to magnesium. |
| A single reassuring CBC. | Counts often fall over days. | Repeat CBC/platelets while trending down. |
| Under-treating hypothermia/hypoglycemia in FGR. | Low reserves decompensate quickly. | Warm early, feed early, monitor glucose. |
| Overlooking polycythemia. | Hyperviscosity symptoms and jaundice. | Check hematocrit if plethoric/symptomatic. |
14. Board-Style High-Yield Summary
Key Takeaways
- Preeclampsia is a placental disease causing indicated preterm birth and fetal growth restriction.
- Neonatal effects come from prematurity, placental insufficiency, and maternal magnesium.
- Classic labs: neutropenia and thrombocytopenia (worse with FGR/HELLP); polycythemia from chronic hypoxia.
- Growth-restricted infants risk hypothermia, hypoglycemia, and perinatal hypoxia.
- Maternal magnesium causes transient neonatal hypotonia/apnea — supportive care.
- HELLP marks severe disease and often prompts urgent delivery.
15. References
- 1.American College of Obstetricians and Gynecologists. Gestational Hypertension and Preeclampsia. ACOG Practice Bulletin.
- 2.Backes CH, et al. Maternal preeclampsia and neonatal outcomes. J Pregnancy. 2011.
- 3.Baylor College of Medicine, Division of Neonatology. Guidelines for Acute Care of the Neonate, Edition 33, 2025–2026.
- 4.Rouse DJ, et al. (BEAM Trial) — antenatal magnesium sulfate and neuroprotection. N Engl J Med. 2008.
- 5.Gomella TL, et al. Neonatology: Management, Procedures, On-Call Problems.
Back to Clinical Guideline Hubs